Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Safety and pharmacokinetics of ribavirin for the treatment of la crosse encephalitis.

McJunkin JE, Nahata MC, De Los Reyes EC, Hunt WG, Caceres M, Khan RR, Chebib MG, Taravath S, Minnich LL, Carr R, Welch CA, Whitley RJ.

Pediatr Infect Dis J. 2011 Oct;30(10):860-5. doi: 10.1097/INF.0b013e31821c922c.

PMID:
21544005
2.
3.

LaCrosse viral encephalitis mimics herpes simplex viral encephalitis.

Sokol DK, Kleiman MB, Garg BP.

Pediatr Neurol. 2001 Nov;25(5):413-5.

PMID:
11744319
4.

Canine LaCrosse viral meningoencephalomyelitis with possible public health implications.

Tatum LM, Pacy JM, Frazier KS, Weege JF, Baldwin CA, Hullinger GA, Bossart GD, Altman NH.

J Vet Diagn Invest. 1999 Mar;11(2):184-8. No abstract available.

PMID:
10098695

Supplemental Content

Loading ...
Support Center